Dr. Stephen Badylak, DVM, PhD, MD is a Professor in the Department of Surgery, and Deputy Director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. Dr. Badylak holds over 60 U.S. patents, 300 patents worldwide, has authored more than 340 scientific publications and 40 book chapters, and has recently edited a textbook entitled “Host Response to Biomaterials”. He has served as the Chair of several study sections at the National Institutes of Health (NIH), and is currently a member of the College of Scientific Reviewers for NIH. More than eight million patients have been treated with bioscaffolds developed in Dr. Badylak’s laboratory. Dr. Badylak is a Fellow of the American Institute for Medical and Biological Engineering, a member of the Society for Biomaterials, a charter member of the Tissue Engineering Society International, a past president of the Tissue Engineering Regenerative Medicine International Society (TERMIS) and a Founding International Fellow of TERMIS.
Professor William Murphy
Professor Bill Murphy, PhD is the Harvey D. Spangler Professor of Biomedical Engineering, Professor of Orthopedics & Rehabilitation, Co-Director of the Stem Cell and Regenerative Medicine Center, and Director of the Human MAPs Center at the University of Wisconsin. His research interests focus on creating new biomaterials inspired by the materials found in nature. Murphy’s research group is using new biomaterials to understand stem cell behavior and to induce tissue regeneration. He has published more than 150 scientific manuscripts, filed over 40 patents, co-founded multiple venture-backed start-up companies, and received awards that include the National Science Foundation Career Award, the Wisconsin Vilas Associate Award, the Romnes Fellowship, and induction as a Fellow in the American Institute for Medical and Biological Engineering.
Dr. Peiman Hematti
Peiman Hematti, MD is a Professor in the Division of Hematology/Oncology/Bone Marrow Transplantation at the Department of Medicine at the University of Wisconsin-Madison. Dr. Hematti completed a combined Internal Medicine/Pediatrics residency at the Cleveland Clinic Foundation and then Clinical Hematology fellowship at the National Heart, Lung, and Blood Institute of the National Institutes of Health. While at NIH he spent 4 years in the laboratory of Dr. Cynthia Dunbar studying the cellular biology hematopoietic stem cells. Dr. Hematti’s participates in clinical care of bone marrow transplant patients. He is also director of Clinical Hematopoietic Cell Processing Laboratory, and medical director of Hematopoietic Cell Collection facility at University of Wisconsin Hospital and Clinics. In that capacity he oversees all peripheral blood and bone marrow collections for hematopoietic cell transplantation or other cellular therapy applications. His clinical research interest is in the use of mesenchymal stem cells for treatment of graft versus host disease and other immune dysregulation disorders, novel cell therapies for hematological malignancies, and use of bone marrow stem cells in regenerative medicine.
Dr. Nancy K. Sweitzer
Nancy K. Sweitzer, MD, PhD, is Director of the UA Sarver Heart Center, Professor of medicine and Chief of the Division of Cardiology in the University of Arizona College of Medicine – Tucson. She is a board-certified advanced heart failure and transplant cardiologist and clinical researcher, specializing in heart failure, mechanical circulatory support and heart transplant patient care. Nationally recognized for her leadership and experience in clinical trials, Dr. Sweitzer’s research program focuses on interaction of the dysfunctional heart muscle in heart failure with other body systems to better understand how to improve symptoms and organ function in heart failure patients. She has done extensive work on the physiology of heart failure with preserved systolic function, a disease that disproportionately affects elderly women.She has led and collaborated on numerous studies sponsored by the National Institutes of Health as well as studies supported by industry and academic sponsors. She has served on numerous NIH committees and currently serves as a member of the Clinical and Integrative Cardiovascular Science Study Section and the American Heart Association’s Cardiac Biology and Regulation Committee.